1. A Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized Oncology (Supportive Care) Trial to Evaluate Comparative Treatment (PROTECT-2), a Phase III, Randomized, Double-Blind Trial. (18th April 2016) Authors: Blackwell, Kimberly; Donskih, Roman; Jones, C. Michael; Nixon, Allen; Vidal, Maria J.; Nakov, Roumen; Singh, Pritibha; Schaffar, Gregor; Gascón, Pere; Harbeck, Nadia Journal: Oncologist Issue: Volume 21:Number 7(2016) Page Start: 789 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Comparison of Proposed Biosimilar LA‐EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early‐Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized Oncology (Supportive Care) Trial to Evaluate Comparative Treatment (PROTECT‐2), a Phase III, Randomized, Double‐Blind Trial. (18th April 2016) Authors: Blackwell, Kimberly; Donskih, Roman; Jones, C. Michael; Nixon, Allen; Vidal, Maria J.; Nakov, Roumen; Singh, Pritibha; Schaffar, Gregor; Gascón, Pere; Harbeck, Nadia Journal: Oncologist Issue: Volume 21:Number 7(2016) Page Start: 789 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A look at current and potential treatment approaches for hormone receptor‐positive, HER2‐negative early breast cancer. (10th May 2022) Authors: Harbeck, Nadia; Burstein, Harold J.; Hurvitz, Sara A.; Johnston, Stephen; Vidal, Gregory A. Journal: Cancer Issue: Volume 128:Supplement S11(2022) Page Start: 2209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Phase II Study of Metronomic Daily Oral Vinorelbine as First-Line Chemotherapy in Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast Cancer Resistant to Endocrine Therapy: Vinometro. (November 2017) Authors: Thomssen, Christoph; Decker, Thomas; Fehm, Tanja; Fuxius, Stefan; Harbeck, Nadia; Juhasz-Böss, Ingolf; Möbus, Volker; Seehase, Martina; Schollenberger, Lukas; Ruckes, Christian; Schmidt, Marcus Journal: Breast Issue: Volume 36(2017)Supplement 1 Page Start: S51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Special Key for Unlocking the Door to Targeted Therapies of Breast Cancer. (2008) Authors: Lindemann, Kristina; Harbeck, Nadia; Lengyel, Ernst; Resau, James H. Other Names: Goette Martin Academic Editor. Journal: TheScientificWorldjournal Issue: Volume 8(2008) Page Start: 905 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial. Issue 1 (January 2023) Authors: Johnston, Stephen R D; Toi, Masakazu; O'Shaughnessy, Joyce; Rastogi, Priya; Campone, Mario; Neven, Patrick; Huang, Chiun-Sheng; Huober, Jens; Jaliffe, Georgina Garnica; Cicin, Irfan; Tolaney, Sara M; Goetz, Matthew P; Rugo, Hope S; Senkus, Elzbieta; Testa, Laura; Del Mastro, Lucia; Shimizu, Chika... Journal: Lancet oncology Issue: Volume 24:Issue 1(2023) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Adjuvant radiotherapy after breast conserving surgery – A comparative effectiveness research study. Issue 1 (January 2015) Authors: Corradini, Stefanie; Niyazi, Maximilian; Niemoeller, Olivier M.; Li, Minglun; Roeder, Falk; Eckel, Renate; Schubert-Fritschle, Gabriele; Scheithauer, Heike R.; Harbeck, Nadia; Engel, Jutta; Belka, Claus Journal: Radiotherapy and oncology Issue: Volume 114:Issue 1(2015:Jan.) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Adjuvant radiotherapy after breast conserving surgery – A comparative effectiveness research study. Issue 1 (January 2015) Authors: Corradini, Stefanie; Niyazi, Maximilian; Niemoeller, Olivier M.; Li, Minglun; Roeder, Falk; Eckel, Renate; Schubert-Fritschle, Gabriele; Scheithauer, Heike R.; Harbeck, Nadia; Engel, Jutta; Belka, Claus Journal: Radiotherapy and oncology Issue: Volume 114:Issue 1(2015:Jan.) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Adjuvant Therapies for Breast Cancer Improve Cure Rates but Appear to Shorten Post-Metastatic Survival. (November 2017) Authors: Harbeck, Nadia; Hölzel, Dieter; Eckel, Renate; Bauerfeind, Ingo; Baier, Bernd; Beck, Thomas; Braun, Michael; Ettl, Johannes; Hamann, Ulrich; Kiechle, Marion; Mahner, Sven; Schindlbeck, Christian; de Waal, Johann; Engel, Jutta Journal: Breast Issue: Volume 36(2017) Page Start: S74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Advances in targeting HER2-positive breast cancer. Issue 1 (February 2018) Authors: Harbeck, Nadia Journal: Current opinion in obstetrics and gynecology Issue: Volume 30:Issue 1(2018:Feb.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗